Impact of switching total bilirubin assays on the classification of neonates at high risk for hyperbilirubinemia
Clin Chem Lab Med
.
2023 Mar 6;61(9):e175-e178.
doi: 10.1515/cclm-2023-0111.
Print 2023 Aug 28.
Authors
Saranya Kittanakom
1
2
,
Jennifer Shea
3
4
,
Felix Leung
2
5
,
Vinh Ly
1
,
Sinthu Panchadcharadevan
1
,
Sangeet Kathuria
1
,
Ivor Margolis
1
,
Vilte Barakauskas
6
,
Peter A Kavsak
7
Affiliations
1
William Osler Health System, Brampton, ON, Canada.
2
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
3
Department of Laboratory Medicine, Saint John Regional Hospital, Horizon Health Network, Saint John, NB, Canada.
4
Department of Pathology, Dalhousie University, Halifax, NS, Canada.
5
Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada.
6
Department of Pathology and Laboratory Medicine, BC Children's and Women's Hospital, Vancouver, BC, Canada.
7
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
PMID:
36872634
DOI:
10.1515/cclm-2023-0111
No abstract available
Keywords:
neonate; phototherapy; total bilirubin.
Publication types
Letter
MeSH terms
Bilirubin
Hematologic Diseases*
Humans
Hyperbilirubinemia, Neonatal* / diagnosis
Infant, Newborn
Substances
Bilirubin